The role of cardiac magnetic resonance (MR) imaging as a prognostic tool in patients with
ischemic heart disease is well established, and MR imaging has been widely trusted in
making clinical decisions regarding suitability for coronary revascularization. Recent efforts
from the scientific imaging community have focused on the potential prognostic role of MR
imaging biomarkers in patients with nonischemic myocardial diseases. In particular, delayed-
enhancement cardiac MR imaging has been interrogated as a tool for risk stratification and …